MedPath

The effect of Supplemetation of ?3 and its combination with Vitamin E in Coronary Artery Disease(CAD).

Not Applicable
Conditions
coronary artery Disease.
Atherosclerotic heart disease
Registration Number
IRCT2013080514273N1
Lead Sponsor
tehran university of medical sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Male
Target Recruitment
60
Inclusion Criteria

? BMI less than 30
? aged 65-45 years
? More than 50% of patients with at least one coronary artery stenosis confirmed by angiography in three months
? Lack of PPAR? agonist drugs such Tyazvlydyn Dion (TZDs), and fiber and taking angiotensin receptor type 1 blockers and inhibitors of non-ACE,
? willingness to cooperate

Criteria excluded:
? kidney disease, liver disease, diabetes, cancer, thyroid disorders, according to the patient's medical history
? smoking (at least 5 threads in the last 6 months)
? omega-3 supplements or fish oil and vitamin E for three months
? Allergy and sensitivity to fish oil
? Lack of cooperation is likely to continue.

Mbar excluded
Any drastic changes in diet (the doctor, the patient himself)

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Gene expression of adiponectin in PBMC. Timepoint: Baseline, After8 weeks. Method of measurement: Realtime PCR.;Gene expression of adiponectin receptors , R1 and R2 in PBMC. Timepoint: Baseline , after 8 weeks. Method of measurement: Realtime PCR.;Gene expression of PPAR gamma in PBMC. Timepoint: Baseline , after 8 weeks. Method of measurement: Realtime PCR.;Serum A-FABP. Timepoint: Baseline , after 8 weeks. Method of measurement: ELISA.;Serum hs-CRP. Timepoint: Baseline , after 8 weeks. Method of measurement: ELISA.;Serum adiponectin. Timepoint: Baseline , after 8 weeks. Method of measurement: ELISA.;Adiponectin / A-FABP. Timepoint: Baseline , after 8 weeks. Method of measurement: Calculate.;Systolic Blood pressure. Timepoint: Baseline , after 8 weeks. Method of measurement: Mercury Sphygmomanometer.;Diastolic Blood pressure. Timepoint: Baseline , after 8 weeks. Method of measurement: Mercury Sphygmomanometer.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath